ArticleVaccine: X2023

Benefit-risk assessment of Covid-19 vaccine, MRNA (MRNA-1273) for males age 18-64 years.

Osman N Yogurtcu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.